Tuesday, Nov. 15, 2016
7:00 p.m. – 8:30 p.m.
Windermere Manor
200 Collip Circle, London, ON (MAP)
**This event has been postponed.**
What if we could engineer a molecule to target cancer cells but leave healthy cells unharmed? Professor Patrick Gunning seeks to do just that with his latest research to design a molecule that targets cancer-regulating proteins called STAT. Gunning has developed a powerful family of molecules that disable the STAT proteins and stops the spread of numerous cancers without the painful side-effects of traditional chemotherapy.
According to the Toronto Star, "[h]is lab, with its 24 students, is enjoying international attention with the design of a drug that cures breast cancer, multiple myeloma and acute lymphoblastic leukemia in mice." Don't miss this opportunity to learn about this ground breaking research in the race to find a cure for cancer.
This event has been postponed.
Hors d’oeuvres will be served. Cash bar.
Please contact Alumni Relations if you require information in an alternate format, or if any other arrangements can make this event accessible to you.
Stay connected through upcoming events.
|
|
home | privacy | events |
